HTG Announces Sub-Contract with Arizona State University to Assess Radiation Exposure

TUCSON, Arizona--(BUSINESS WIRE)--HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™), today announced it has signed a contract with Arizona State University to provide gene expression assay and development services as part of a multi-institutional research program. As the core gene expression technology in the program, HTG’s qNPA technology will be used to build tests that rapidly measure an individual’s level of exposure to radiation in the event of a radiological or nuclear incident.